ALHC insider buying and SEC filings, explained
Alignment Healthcare, Inc. · CIK 1832466
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$198K
Insiders who bought
1
Sold (not marked 10b5-1)
$439.1M
Planned sales (10b5-1)
$81.5M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 6, 2026 | Sale | Hyong Kim (Chief Medical Officer) sold 32,479 shares at about $8.30 ($270K). Holdings down 10% to 299,271 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 7, 2026, 4:00 PM ET |
| Sep 17, 2026 | Sale | Joseph S. Konowiecki (Director and EVP, Corporate Affairs) sold 23,511 shares at about $8.61 ($202K). Holdings down 2% to 1,080,305 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 18, 2026 |
| Sep 14, 2026 | Planned (10b5-1) | John E. Kao (CEO and Director) sold 27,400 shares indirectly at $13.00 ($356K), marked as a 10b5-1 plan trade. Indirect holdings down 4% to 590,766 shares. | SEC filing Filed Sep 16, 2026 |
| Sep 11, 2026 | Sale | Dawn Christine Maroney (President / COO) sold 122,707 shares at about $12.68 ($1.6M). Holdings down 13% to 794,606 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 11, 2026 |
| Sep 10–11, 2026 | Planned (10b5-1) | John E. Kao (CEO and Director) sold 557,870 shares directly and indirectly between Sep 10 and Sep 11 at about $12.77 ($7.1M), marked as a 10b5-1 plan trade. Direct holdings down 24% to 1,223,473 shares. | SEC filing Filed Sep 11, 2026 |
| Aug 14, 2026 | Planned (10b5-1) | Dawn Christine Maroney (President / COO) sold 5,000 shares at $14.00 ($70K), marked as a 10b5-1 plan trade. Holdings down 1% to 917,313 shares. | SEC filing Filed Aug 18, 2026 |
| Aug 10, 2026 | Planned (10b5-1) | John E. Kao (CEO and Director) sold 298,000 shares indirectly at about $13.88 ($4.1M), marked as a 10b5-1 plan trade. Indirect holdings down 27% to 790,766 shares. | SEC filing Filed Aug 10, 2026 |
| Jul 15, 2026 | Planned (10b5-1) | Dawn Christine Maroney (President / COO) sold 177,068 shares at about $20.83 ($3.7M), marked as a 10b5-1 plan trade. Holdings down 16% to 922,313 shares. | SEC filing Filed Jul 16, 2026 |
| Jul 10, 2026 | Planned (10b5-1) | John E. Kao (CEO and Director) sold 298,000 shares indirectly at about $19.86 ($5.9M), marked as a 10b5-1 plan trade. Indirect holdings down 21% to 1,088,766 shares. | SEC filing Filed Jul 14, 2026 |
| Jul 1, 2026 | Planned (10b5-1) | Joseph S. Konowiecki (Director and EVP, Corporate Affairs) sold 25,000 shares at $24.00 ($600K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,103,816 shares. | SEC filing Filed Jul 1, 2026 |
| Jun 26, 2026 | Planned (10b5-1) | Joseph S. Konowiecki (Director and EVP, Corporate Affairs) sold 25,000 shares at $23.00 ($575K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,128,816 shares. | SEC filing Filed Jun 26, 2026 |
| Jun 18, 2026 | Planned (10b5-1) | Joseph S. Konowiecki (Director and EVP, Corporate Affairs) sold 25,000 shares at $22.00 ($550K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,153,816 shares. | SEC filing Filed Jun 18, 2026 |
| Jun 15, 2026 | Planned (10b5-1) | Dawn Christine Maroney (President / COO) sold 30,000 shares at about $19.55 ($587K), marked as a 10b5-1 plan trade. Holdings down 3% to 947,313 shares. | SEC filing Filed Jun 15, 2026 |
| Jun 12, 2026 | Planned (10b5-1) | Hyong Kim (Chief Medical Officer) sold 35,951 shares at about $19.86 ($714K), marked as a 10b5-1 plan trade. Holdings down 10% to 331,750 shares. | SEC filing Filed Jun 15, 2026 |
| Jun 11, 2026 | Planned (10b5-1) | Joseph S. Konowiecki (Director and EVP, Corporate Affairs) sold 25,000 shares at $21.00 ($525K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,178,816 shares. | SEC filing Filed Jun 12, 2026 |
| Jun 10, 2026 | Planned (10b5-1) | John E. Kao (CEO and Director) sold 298,000 shares indirectly at about $20.36 ($6.1M), marked as a 10b5-1 plan trade. Indirect holdings down 18% to 1,386,766 shares. | SEC filing Filed Jun 12, 2026 |
| Jun 2, 2026 | Purchase (code P) | Mark D. Kent (President / COO) bought 14,848 shares at $13.31 ($198K), reported as a purchase (code P). New position of 14,848 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 2, 2026 |
| May 15, 2026 | Planned (10b5-1) | Dawn Christine Maroney (President / COO) sold 30,000 shares at about $16.09 ($483K), marked as a 10b5-1 plan trade. Holdings down 3% to 998,813 shares. | SEC filing Filed May 19, 2026 |
| May 11, 2026 | Planned (10b5-1) | John E. Kao (CEO and Director) sold 298,000 shares indirectly at about $16.89 ($5.0M), marked as a 10b5-1 plan trade. Indirect holdings down 16% to 1,508,641 shares. | SEC filing Filed May 13, 2026 |
| Apr 15, 2026 | Planned (10b5-1) | Dawn Christine Maroney (President / COO) sold 30,000 shares at about $20.87 ($626K), marked as a 10b5-1 plan trade. Holdings down 3% to 1,028,813 shares. | SEC filing Filed Apr 15, 2026 |
| Apr 10–13, 2026 | Planned (10b5-1) | John E. Kao (CEO and Director) sold 298,000 shares indirectly between Apr 10 and Apr 13 at about $20.68 ($6.2M), marked as a 10b5-1 plan trade. Indirect holdings down 14% to 1,806,641 shares. | SEC filing Filed Apr 13, 2026 |
| Apr 7, 2026 | Sale | James M Head (CFO) sold 11,100 shares at $21.08 ($234K). Holdings down 6% to 173,495 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 8, 2026 |
| Apr 7, 2026 | Planned (10b5-1) | John E. Kao (CEO and Director) sold 250,000 shares indirectly at about $21.01 ($5.3M), marked as a 10b5-1 plan trade. Indirect holdings down 11% to 2,104,641 shares. | SEC filing Filed Apr 8, 2026 |
| Apr 1, 2026 | Planned (10b5-1) | Christopher J. Joyce (Chief Legal and Admin. Officer) sold 18,013 shares at about $17.79 ($320K), marked as a 10b5-1 plan trade. Holdings down 6% to 305,451 shares. | SEC filing Filed Apr 1, 2026 |
| Mar 23, 2026 | Planned (10b5-1) | John E. Kao (CEO and Director) sold 118,000 shares indirectly at about $17.48 ($2.1M), marked as a 10b5-1 plan trade. Indirect holdings down 5% to 2,354,641 shares. | SEC filing Filed Mar 23, 2026 |
| Mar 18, 2026 | Sale | Sebastian Burzacchi (President / COO) sold 15,361 shares at about $17.84 ($274K). Holdings down 6% to 258,630 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 19, 2026 |
| Mar 18, 2026 | Sale | Hyong Kim (Chief Medical Officer) sold 18,404 shares at about $17.84 ($328K). Holdings down 5% to 367,701 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 19, 2026 |
| Mar 18, 2026 | Sale | Christopher J. Joyce (Chief Legal and Admin. Officer) sold 25,125 shares at about $17.84 ($448K). Holdings down 7% to 323,464 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 19, 2026 |
| Mar 18, 2026 | Sale | Dawn Christine Maroney (President / COO) sold 36,749 shares at about $17.84 ($656K). Holdings down 3% to 1,058,813 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 19, 2026 |
| Mar 18, 2026 | Sale | John E. Kao (CEO and Director) sold 73,046 shares at about $17.84 ($1.3M). Holdings down 4% to 1,784,868 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 19, 2026 |
| Mar 18, 2026 | Sale | Robert L. Scavo (Chief Information Officer) sold 11,285 shares at about $17.84 ($201K). Holdings down 2% to 487,685 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 19, 2026 |
| Mar 18–19, 2026 | Planned (10b5-1) | Andreas P. Wagner (Chief Human Resources Officer) sold 23,602 shares between Mar 18 and Mar 19 at about $18.03 ($425K), marked as a 10b5-1 plan trade. Holdings down 14% to 148,628 shares. | SEC filing Filed Mar 19, 2026 |
| Mar 16, 2026 | Planned (10b5-1) | Dawn Christine Maroney (President / COO) sold 30,000 shares at about $17.48 ($524K), marked as a 10b5-1 plan trade. Holdings down 3% to 1,095,562 shares. | SEC filing Filed Mar 17, 2026 |
| Mar 12, 2026 | Sale | Robert L. Scavo (Chief Information Officer) sold 4,044 shares at about $17.45 ($71K). Holdings down 1% to 498,970 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 13, 2026 |
| Mar 12, 2026 | Sale | Dawn Christine Maroney (President / COO) sold 29,113 shares at about $17.45 ($508K). Holdings down 3% to 963,702 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 13, 2026 |
| Mar 12, 2026 | Sale | John E. Kao (CEO and Director) sold 48,899 shares at about $17.45 ($853K). Holdings down 3% to 1,519,480 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 13, 2026 |
| Mar 10, 2026 | Planned (10b5-1) | John E. Kao (CEO and Director) sold 180,000 shares indirectly at about $18.19 ($3.3M), marked as a 10b5-1 plan trade. Indirect holdings down 7% to 2,472,641 shares. | SEC filing Filed Mar 10, 2026 |
| Mar 4, 2026 | Planned (10b5-1) | Andreas P. Wagner (Chief Human Resources Officer) sold 21,118 shares at about $18.62 ($393K), marked as a 10b5-1 plan trade. Holdings down 12% to 148,687 shares. | SEC filing Filed Mar 4, 2026 |
| Feb 17, 2026 | Planned (10b5-1) | Dawn Christine Maroney (President / COO) sold 30,000 shares at about $20.63 ($619K), marked as a 10b5-1 plan trade. Holdings down 3% to 997,015 shares. | SEC filing Filed Feb 17, 2026 |
| Feb 10, 2026 | Sale | Andreas P. Wagner (Chief Human Resources Officer) sold 22,238 shares at $20.47 ($455K). Holdings down 12% to 169,805 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 10, 2026 |
| Feb 10, 2026 | Planned (10b5-1) | John E. Kao (CEO and Director) sold 180,000 shares indirectly at about $20.49 ($3.7M), marked as a 10b5-1 plan trade. Indirect holdings down 6% to 2,652,641 shares. | SEC filing Filed Feb 10, 2026 |
| Jan 15, 2026 | Planned (10b5-1) | Dawn Christine Maroney (President / COO) sold 30,000 shares at about $22.48 ($674K), marked as a 10b5-1 plan trade. Holdings down 3% to 1,027,015 shares. | SEC filing Filed Jan 16, 2026 |
| Jan 12, 2026 | Planned (10b5-1) | John E. Kao (CEO and Director) sold 180,000 shares indirectly at about $21.11 ($3.8M), marked as a 10b5-1 plan trade. Indirect holdings down 6% to 2,832,641 shares. | SEC filing Filed Jan 14, 2026 |
| Jan 6, 2026 | Planned (10b5-1) | Hyong Kim (Chief Medical Officer) sold 16,506 shares at about $21.35 ($352K), marked as a 10b5-1 plan trade. Holdings down 5% to 333,133 shares. | SEC filing Filed Jan 6, 2026 |
| Jan 2, 2026 | Planned (10b5-1) | Christopher J. Joyce (Chief Legal and Admin. Officer) sold 10,611 shares at about $20.03 ($213K), marked as a 10b5-1 plan trade. Holdings down 3% to 297,088 shares. | SEC filing Filed Jan 6, 2026 |
| Jan 2–6, 2026 | Planned (10b5-1) | Dawn Christine Maroney (President / COO) sold 328,152 shares between Jan 2 and Jan 6 at about $20.93 ($6.9M), marked as a 10b5-1 plan trade. Holdings down 24% to 1,057,015 shares. | SEC filing Filed Jan 6, 2026 |
| Dec 29, 2025 | Sale | Robert L. Scavo (Chief Information Officer) sold 69,541 shares at about $18.75 ($1.3M). Holdings down 12% to 503,014 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 30, 2025 |
| Dec 29, 2025 | Sale | Hyong Kim (Chief Medical Officer) sold 12,694 shares at about $18.75 ($238K). Holdings down 4% to 349,639 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 30, 2025 |
| Dec 29, 2025 | Sale | John E. Kao (CEO and Director) sold 605,648 shares at about $18.75 ($11.4M). Holdings down 21% to 2,234,294 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 30, 2025 |
| Dec 29, 2025 | Sale | Dawn Christine Maroney (President / COO) sold 282,070 shares at about $18.75 ($5.3M). Holdings down 17% to 1,385,167 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 30, 2025 |
| Dec 29, 2025 | Sale | Christopher J. Joyce (Chief Legal and Admin. Officer) sold 16,187 shares at about $18.75 ($303K). Holdings down 5% to 307,699 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 30, 2025 |
| Dec 12–15, 2025 | Planned (10b5-1) | Dawn Christine Maroney (President / COO) sold 130,000 shares between Dec 12, 2025 and Dec 15, 2025 at about $20.01 ($2.6M), marked as a 10b5-1 plan trade. Holdings down 7% to 1,667,237 shares. | SEC filing Filed Dec 15, 2025 |
| Dec 12, 2025 | Sale | General Atlantic (ALN HLTH), L.P. (10% owner) sold 11,119,494 shares indirectly at $18.57 ($206.5M). Indirect holdings down 45% to 13,476,585 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 12, 2025 |
| Dec 12, 2025 | Sale | GENERAL ATLANTIC, L.P. (10% owner) sold 11,119,494 shares indirectly at $18.57 ($206.5M). Indirect holdings down 45% to 13,476,585 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 9 other reporting owners. | SEC filing Filed Dec 12, 2025 |
| Dec 10, 2025 | Sale | Sebastian Burzacchi (President / COO) sold 12,585 shares at $19.26 ($242K). Holdings down 5% to 237,793 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 12, 2025 |
| Dec 10, 2025 | Planned (10b5-1) | John E. Kao (CEO and Director) sold 180,000 shares indirectly at about $19.02 ($3.4M), marked as a 10b5-1 plan trade. Indirect holdings down 7% to 2,346,726 shares. | SEC filing Filed Dec 12, 2025 |
| Dec 8, 2025 | Planned (10b5-1) | Christopher J. Joyce (Chief Legal and Admin. Officer) sold 19,706 shares at about $19.33 ($381K), marked as a 10b5-1 plan trade. Holdings down 6% to 323,886 shares. | SEC filing Filed Dec 8, 2025 |
| Nov 25, 2025 | Planned (10b5-1) | Joseph S. Konowiecki (Director) sold 25,000 shares at $19.00 ($475K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,056,141 shares. | SEC filing Filed Nov 26, 2025 |
| Nov 11, 2025 | Sale | Joseph S. Konowiecki (Director) sold 4,832 shares at $16.49 ($80K). Holdings down <1% to 1,081,141 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 12, 2025 |
| Nov 10, 2025 | Planned (10b5-1) | John E. Kao (CEO and Director) sold 180,000 shares indirectly at about $16.32 ($2.9M), marked as a 10b5-1 plan trade. Indirect holdings down 7% to 2,526,726 shares. | SEC filing Filed Nov 12, 2025 |
23 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow ALHC in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.